Most Recent
Qld tech firm denies using confidential info for battery patent applications
Intellectual Property 2023-10-02 10:00 pm By Cindy Cameronne

Queensland technology company Anteotech has hit back at a lawsuit claiming it misused Ferroglobe’s confidential silicon samples in a patent application after a failed collaboration, […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Novartis can’t have separate trial on blood pressure drug invalidity claim
Intellectual Property 2023-08-18 10:04 pm By Cindy Cameronne

Novartis has lost its bid to have Pharmacor’s claim that its patent for a blood pressure drug is invalid decided ahead of a main trial […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Ferroglobe accuses ASX company of using confidential IP after failed collaboration
Intellectual Property 2023-07-19 10:52 pm By Gareth Baker

Ferroglobe has claimed a Queensland technology company used its confidential information in new patent applications, as the global specialty metals producer races to protect its […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

‘Substantial industrial theft’: Hytera to face damages for stealing Motorola’s source code
Intellectual Property 2022-12-23 8:59 pm By Cat Fredenburgh

A judge has found Shenzhen-based based radio manufacturer Hytera engaged in “substantial industrial theft” by appropriating Motorola’s source code for its digital mobile radios and […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Novartis, Pharmacor resolve suit over Gilenya patents
Intellectual Property 2022-11-14 1:42 pm By Cat Fredenburgh

Novartis and and generic drug maker Pharmacor have resolved litigation over the Swiss pharmaceutical giant’s patents for blockbuster MS drug Gilenya. Novartis sued NSW-based Pharmacor […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Biogen, Pharmacor lay down swords in battle over MS drug patent
Intellectual Property 2022-10-31 11:01 pm By Cat Fredenburgh

Swiss pharmaceutical company Biogen and Australian generic drug maker Pharmacor have dropped their claims against one another in a lawsuit over the patent for MS […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Defamation, class action barristers among 20 new silks
People In The News 2022-10-06 6:03 pm By Sam Matthews

Twenty barristers have risen to the ranks of senior counsel in New South Wales, including a veteran defamation barrister, two counsel with class action expertise […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Full Court upholds validity of Pfizer’s Dynastat patent
Intellectual Property 2022-09-30 4:58 pm By Cindy Cameronne

A judge has thrown out competing appeals of a decision finding Pfizer’s patent for its post-operative injectable painkiller Dynastat is valid and that drug maker […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Bangkok Broadcasting settles ‘7’ trade mark stoush with Seven Network
Intellectual Property 2022-09-05 9:55 pm By Cat Fredenburgh

Bangkok Broadcasting and Seven Networks have settled two lawsuits over the Thai broadcaster’s registration of ‘7’ marks in Australia. Bangkok Broadcasting & TV runs a […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Pfizer sues drug companies over Enbrel biosimilar
Intellectual Property 2022-05-10 11:38 pm By Cat Fredenburgh

Pharmaceutical giant Pfizer has fired off a lawsuit against four drug companies for allegedly infringing one of its patents for biologic Enbrel by selling a […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.